These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 22108576)

  • 1. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
    Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
    Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
    Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
    Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
    den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
    Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
    Pereira JB; Hall S; Jalakas M; Grothe MJ; Strandberg O; Stomrud E; Westman E; van Westen D; Hansson O
    Neurobiol Dis; 2020 Jun; 139():104831. PubMed ID: 32145376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
    Charissé D; Erus G; Pomponio R; Gorges M; Schmidt N; Schneider C; Liepelt-Scarfone I; Riedel O; Reetz K; Schulz JB; Berg D; Storch A; Witt K; Dodel R; Kalbe E; Kassubek J; Hilker-Roggendorf R; Baudrexel S
    Neurobiol Aging; 2022 Jan; 109():31-42. PubMed ID: 34649002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
    Baumeister H; Vogel JW; Insel PS; Kleineidam L; Wolfsgruber S; Stark M; Gellersen HM; Yakupov R; Schmid MC; Lüsebrink F; Brosseron F; Ziegler G; Freiesleben SD; Preis L; Schneider LS; Spruth EJ; Altenstein S; Lohse A; Fliessbach K; Vogt IR; Bartels C; Schott BH; Rostamzadeh A; Glanz W; Incesoy EI; Butryn M; Janowitz D; Rauchmann BS; Kilimann I; Goerss D; Munk MH; Hetzer S; Dechent P; Ewers M; Scheffler K; Wuestefeld A; Strandberg O; van Westen D; Mattsson-Carlgren N; Janelidze S; Stomrud E; Palmqvist S; Spottke A; Laske C; Teipel S; Perneczky R; Buerger K; Schneider A; Priller J; Peters O; Ramirez A; Wiltfang J; Heneka MT; Wagner M; Düzel E; Jessen F; Hansson O; Berron D
    Brain; 2024 Jul; 147(7):2400-2413. PubMed ID: 38654513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.
    Labrador-Espinosa MA; Silva-Rodríguez J; Reina-Castillo MI; Mir P; Grothe MJ
    Mov Disord; 2023 Oct; 38(10):1871-1880. PubMed ID: 37492892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
    Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
    BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.